iSBTc Active Committees for 2008

Committees Home   |   Collaborations   |   Constitution and Bylaws   |   Development   |   Membership
Public Relations, Publications, and Communication   |   Scientific Program Committee   |   iSBTc Executive Council

Development Committee

The Development Committee is responsible for proposing and carrying out fundraising activities in support of the Society and its objectives. This Committee maintains all sponsor information and directs the assignment of Society members to solicit potential sponsors based on his or her professional contacts and/or area of expertise. This Committee determines which sponsors should be targeted for funding of certain programs and assists Society members in tailoring their approach to sponsors. This Committee develops strategies to achieve those goals set by the President and Committee members as well as those that enhance the Society's profitability in pursuit of such goals.

Chair

Jared A. Gollob, MD
Alnylam Pharmaceuticals

Vice Chair

Kim A. Margolin, MD
City of Hope

Core Members

Ernest C. Borden, MD
Cleveland Clinic Foundation

Bernard A. Fox, PhD
Earle A. Chiles Research Institute

Thomas F. Gajewski, MD, PhD
University of Chicago

Patrick Hwu, MD
MD Anderson Cancer Center

Jon M. Wigginton, MD
Merck & Co., Inc.

Associate Members

Lisa M. Coussens, PhD
University of California, San Francisco

Thomas A. Davis, MD
Celldex Therapeutics, Inc.

Steven Dubinett, MD
University of California Los Angeles

Michael Karin, PhD
University of California, San Diego

William J. Murphy, PhD
University of Nevada School of Medicine

Hideaki Tahara, MD, PhD
University of Tokyo

George J. Weiner, MD
University of Iowa